| Omar Haider Rizvi, MD | |
|
1955 W Frye Rd, Chandler, AZ 85224-6282 | |
| (480) 728-4979 | |
| Not Available |
| Full Name | Omar Haider Rizvi |
|---|---|
| Gender | Male |
| Speciality | Student In An Organized Health Care Education/training Program |
| Location | 1955 W Frye Rd, Chandler, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720723968 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | R79488 (Arizona) | Secondary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Omar Haider Rizvi, MD 1955 W Frye Rd, Chandler, AZ 85224-6282 Ph: (480) 728-4979 | Omar Haider Rizvi, MD 1955 W Frye Rd, Chandler, AZ 85224-6282 Ph: (480) 728-4979 |
News Archive
Developed in collaboration with the Oxidative Stress Group at the University of Leicester (Leicester, UK), the unique design of the COMPAC-50 enables simultaneous electrophoresis of up to 50 COMET Assay slides saving considerable lab space and reducing slide handling time by up to two-thirds when compared to previous standard methods. This would equate to a significant time-saving of up to 90% when handling 50 COMET Assay slides.
The Children's Hospital and the University of Colorado Hospital have finalized an agreement to jointly establish a center for advanced maternal fetal medicine offering state-of-the-art care for high-risk pregnant women and their babies. The two leading academic medical centers have individually provided such services for more than three decades, and by building on already existing adult and pediatric expertise, they together will be able to provide unparalleled care and treatment for the region's most at-risk moms and babies.
There have been several news reports that the world's first dengue vaccine will be available next year. However, the latest clinical trials show that the vaccine only provides a protection of around 50 per cent for DENV-2 and DENV-1, which are commonly found in Singapore.
Continucare Corporation (NYSE Amex:CNU) announced today that it has expanded its sleep diagnostic division with the acquisition of two additional centers. Seredor Corporation, Continucare's newly established subsidiary, has purchased the assets of Sleep Disorder Solutions, Inc., a full service operator of sleep diagnostic centers, with sleep diagnostic centers in South Miami and Pembroke Pines, Florida.
› Verified 7 days ago